Guido H. Sauter

Guido H. Sauter

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 465 publications

Using large-scale tissue microarray resources for the identification and evaluation of old, new, and novel targets for surgical pathology.

Using large-scale tissue microarray resources for the identification and evaluation of old, new, and novel targets for surgical pathology.

Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists

Published: July 10, 2026

TROP2 Is Uniformly Expressed in Primary Prostate Cancer but Frequently Reduced in Recurrent Disease.

TROP2 Is Uniformly Expressed in Primary Prostate Cancer but Frequently Reduced in Recurrent Disease.

Journal: Cancers

Published: May 31, 2026

Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.

Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.

Journal: Biomedicines

Published: February 17, 2026

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

Journal: Diagnostics (Basel, Switzerland)

Published: February 16, 2026

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.

Journal: Frontiers in oncology

Published: February 12, 2026

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Journal: Molecular medicine (Cambridge, Mass.)

Published: December 16, 2025

Low E-cadherin expression is associated with poor prognosis in pulmonal adenocarcinoma.

Low E-cadherin expression is associated with poor prognosis in pulmonal adenocarcinoma.

Journal: Scientific reports

Published: December 15, 2025

DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.

DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.

Journal: Cell reports. Medicine

Published: November 28, 2025

Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types.

Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types.

Journal: Virchows Archiv : an international journal of pathology

Published: November 04, 2025

Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes.

Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes.

Journal: Cancers

Published: October 26, 2025

Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP®).

Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP®).

Journal: Cancers

Published: October 16, 2025

PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder Carcinomas.

PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder Carcinomas.

Journal: Genes, chromosomes & cancer

Published: August 28, 2025

Showing 1-12 of 465

Last Updated: 09/26/2026